ARKG Overview | ARK Genomic Revolution ETF - Strategy, Holdings & Performance

ARKG (ARK Genomic Revolution ETF) — Investment strategy, top holdings, Cathie Wood's thesis, and latest performance. Free independent tracker.

ARKG — ARK Genomic Revolution ETF

ARKG (ARK Genomic Revolution ETF) currently holds 32 stocks worth $2.18B as of September 22, 2026. The largest position is TXG at 9.51%, followed by TWST at 9.40% and TEM at 8.87%. ARK Invest discloses holdings daily and this tracker syncs the official portfolio file within hours.

ARKG Top 10 Holdings (as of September 22, 2026)

RankTickerCompanyWeightMarket ValueShares
1TXG10x Genomics, Inc.9.51%$208.1M2,630,820
2TWSTTwist Bioscience Corporation9.40%$205.7M1,240,604
3TEMTEMPUS AI INC-CL A8.87%$194.2M2,489,383
4CRSPCRISPR THERAPEUTICS AG5.76%$126.1M2,162,253
5PSNLPERSONALIS INC5.08%$111.1M6,844,139
6ABSIABSCI CORP4.81%$105.3M10,721,325
7GHGUARDANT HEALTH INC4.69%$102.6M590,296
8NTRANATERA INC4.24%$92.8M250,243
9ILMNILLUMINA INC4.09%$89.5M374,931
10CDNACAREDX INC3.78%$82.8M1,524,788

ARKG is one of ARK Invest's actively managed innovation ETFs. Cathie Wood's team selects positions based on disruptive innovation themes — the fund publishes its full holdings and every trade with same-day transparency.

For live data see ARKG holdings and ARKG daily trades.